Skip to main content
SpringerLink
Log in

General Considerations on Treatment in Older Patients with Hematological Malignancies

  • Chapter
  • First Online:
Management of Hematological Cancer in Older People

  • 771 Accesses

Abstract

Standard treatment relates to disease, not to patients. The question in older patients is consequently most often to adapt standard treatment to the specific situation of the patient through a strict evaluation of risks and benefits since higher risks may consume benefits.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mohile SG, Xian Y, Dale W, Fisher SG, Rodin M, Morrow GR, et al. Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst. 2009;101(17):1206–15.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist. 2000;5(3):224–37.

    Article  CAS  PubMed  Google Scholar 

  3. Saliba D, Elliott M, Rubenstein LZ, Solomon DH, Young RT, Kamberg CJ, et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49(12):1691–9.

    Article  CAS  PubMed  Google Scholar 

  4. McNeil C. Geriatric oncology clinics on the rise. J Natl Cancer Inst. 2013;105(9):585–6.

    Article  PubMed  Google Scholar 

  5. Stuck AE, Siu AL, Wieland GD, Adams J, Rubenstein LZ. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet. 1993;342(8878):1032–6.

    Article  CAS  PubMed  Google Scholar 

  6. Soubeyran P. From suboptimal to optimal treatment in older patients with cancer. J Geriatr Oncol. 2013;4:291–3.

    Article  PubMed  Google Scholar 

  7. Wedding U, Ködding D, Pientka L, Steinmetz HT, Schmitz S. Physicians’ judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy. Crit Rev Oncol Hematol. 2007;64(1):1–9.

    Article  PubMed  Google Scholar 

  8. Tucci A, Ferrari S, Bottelli C, Borlenghi E, Drera M, Rossi G. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer. 2009;115(19):4547–53.

    Article  PubMed  Google Scholar 

  9. Spina M, Balzarotti M, Uziel L, Ferreri AJ, Fratino L, Magagnoli M, et al. Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma. Oncologist. 2012;17(6):838–46.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA. 2006;295(7):801–8.

    Article  CAS  PubMed  Google Scholar 

  11. Schonberg MA, Davis RB, McCarthy EP, Marcantonio ER. Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med. 2009;24(10):1115–22.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Ouellette JR, Small DG, Termuhlen PM. Evaluation of Charlson-Age Comorbidity Index as predictor of morbidity and mortality in patients with colorectal carcinoma. J Gastrointest Surg. 2004;8(8):1061–7.

    Article  PubMed  Google Scholar 

  13. Louwman WJ, Janssen-Heijnen ML, Houterman S, Voogd AC, van der Sangen MJ, Nieuwenhuijzen GA, et al. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer. 2005;41(5):779–85.

    Article  CAS  PubMed  Google Scholar 

  14. Freyer G, Geay JF, Touzet S, Provencal J, Weber B, Jacquin JP, et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol. 2005;16(11):1795–800.

    Article  CAS  PubMed  Google Scholar 

  15. Soubeyran P, Fonck M, Blanc-Bisson C, Blanc JF, Ceccaldi J, Mertens C, et al. Predictors of early death risk in older patients treated by first-line chemotherapy for cancer. J Clin Oncol. 2012;30(15):1829–34.

    Article  PubMed  Google Scholar 

  16. Gomez H, Hidalgo M, Casanova L, Colomer R, Pen DL, Otero J, et al. Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin’s lymphoma: results of a multivariate analysis. J Clin Oncol. 1998;16(6):2065–9.

    CAS  PubMed  Google Scholar 

  17. Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20(2):494–502.

    Article  PubMed  Google Scholar 

  18. Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457–65.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012;118(13):3377–86.

    Article  PubMed  Google Scholar 

  20. Warkus T, Rainfray M, Fonck M, Bellera C, Blanc-Bisson C, Blanc JF, et al. Low MNA score and thrombacytopenia are predictive of unexpected hospital admission during treatment in elderly patients receiving chemotherapy. J Geriatr Oncol. 2011;2 Suppl 1:S46.

    Google Scholar 

  21. Hoppe S, Rainfray M, Fonck M, Hoppenreys L, Blanc JF, Ceccaldi J, et al. Functional decline in older patients with cancer receiving first-line chemotherapy. J Clin Oncol. 2013;31(31):3877–82.

    Article  PubMed  Google Scholar 

  22. Aparicio T, Jouve JL, Teillet L, Gargot D, Subtil F, Le Brun-Ly V, et al. Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001–02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients. J Clin Oncol. 2013;31(11):1464–70.

    Article  CAS  PubMed  Google Scholar 

  23. Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol. 2007;25(25):3808–15.

    Article  CAS  PubMed  Google Scholar 

  24. Hershman DL, McBride RB, Eisenberger A, Tsai WY, Grann VR, Jacobson JS. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin’s lymphoma. J Clin Oncol. 2008;26(19):3159–65.

    Article  CAS  PubMed  Google Scholar 

  25. Aapro M, Bernard-Marty C, Brain EGC, Batist G, Erdkamp F, Krzemieniecki K, et al. Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Ann Oncol. 2011;22(2):257–67.

    Article  CAS  PubMed  Google Scholar 

  26. Tofthagen C, Overcash J, Kip K. Falls in persons with chemotherapy-induced peripheral neuropathy. Support Care Cancer. 2012;20(3):583–9.

    Article  PubMed  Google Scholar 

  27. McMillan DC, Canna K, McArdle CS. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg. 2003;90(2):215–9.

    Article  CAS  PubMed  Google Scholar 

  28. Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, Kim BG, et al. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer. 2009;9:155.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Stark JR, Li H, Kraft P, Kurth T, Giovannucci EL, Stampfer MJ, et al. Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality. Int J Cancer. 2009;124(11):2683–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Proctor MJ, Morrison DS, Talwar D, Balmer SM, O'Reilly DS, Foulis AK, et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer. 2011;104(4):726–34.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Alexandre J, Gross-Goupil M, Falissard B, Nguyen ML, Gornet JM, Misset JL, et al. Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy. Ann Oncol. 2003;14(1):36–41.

    Article  CAS  PubMed  Google Scholar 

  32. Zauderer MG, Sima CS, Korc-Grodzicki B, Kris MG, Krug LM. Toxicity of initial chemotherapy in older patients with lung cancers. J Geriatr Oncol. 2013;4(1):64–70.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Extermann M, Aapro M, Audisio R, Balducci L, Droz JP, Steer C et al. SIOG 10 priorities. 1-2-2011.

    Google Scholar 

  34. Mohile SG, Bylow K, Dale W, Dignam J, Martin K, Petrylak DP, et al. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer. 2007;109(4):802–10.

    Article  PubMed  Google Scholar 

  35. Luciani A, Ascione G, Bertuzzi C, Marussi D, Codeca C, Di MG, et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol. 2010;28(12):2046–50.

    Article  PubMed  Google Scholar 

  36. Soubeyran P, Bellera C, Goyard J, Heitz D, Curé H, Rousselot H, et al. Validation of the G8 screening tool in geriatric oncology: the ONCODAGE project. J Clin Oncol. 2011;29(15S Part I):550 s.

    Google Scholar 

  37. Luciani A, Dottorini L, Battisti N, Bertuzzi C, Caldiera S, Floriani I, et al. Screening elderly cancer patients for disabilities: evaluation of study of osteoporotic fractures (SOF) index and comprehensive geriatric assessment (CGA). Ann Oncol. 2013;24(2):469–74.

    Article  CAS  PubMed  Google Scholar 

  38. Biganzoli L, Boni L, Becheri D, Zafarana E, Biagioni C, Cappadona S, et al. Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool? Ann Oncol. 2013;24(2):494–500.

    Article  CAS  PubMed  Google Scholar 

  39. Bellera CA, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23:2166–72.

    Article  CAS  PubMed  Google Scholar 

  40. Kenis C, Decoster L, Vanpuyvelde K, de Greve J, Conings G, Milisen K, et al. Performance of two geriatric screening tools in older cancer patients. Eur J Cancer. 2013;49 Suppl 2:S338.

    Google Scholar 

  41. Barber JH, Wallis JB, McKeating E. A postal screening questionnaire in preventive geriatric care. J R Coll Gen Pract. 1980;30(210):49–51.

    CAS  PubMed Central  PubMed  Google Scholar 

  42. Molina-Garrido MJ, Guillen-Ponce C. Comparison of two frailty screening tools in older women with early breast cancer. Crit Rev Oncol Hematol. 2011;79(1):51–64.

    Article  CAS  PubMed  Google Scholar 

  43. Hurria A, Gupta S, Zauderer M, Zuckerman EL, Cohen HJ, Muss H, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005;104(9):1998–2005.

    Article  PubMed  Google Scholar 

  44. Overcash JA, Beckstead J, Moody L, Extermann M, Cobb S. The abbreviated comprehensive geriatric assessment (aCGA) for use in the older cancer patient as a prescreen: scoring and interpretation. Crit Rev Oncol Hematol. 2006;59(3):205–10.

    Article  PubMed  Google Scholar 

  45. Slaets JP. Vulnerability in the elderly: frailty. Med Clin North Am. 2006;90(4):593–601.

    Article  PubMed  Google Scholar 

  46. Extermann M, Green T, Tiffenberg G, Rich C. Validation of the Senior Adult Oncology Program (SAOP) 2 screening questionnaire. Crit Rev Oncol Hematol. 2009;69(2):183–5.

    Article  Google Scholar 

  47. Kellen E, Bulens P, Deckx L, Schouten H, Van Dijk M, Verdonck I, et al. Identifying an accurate pre-screening tool in geriatric oncology. Crit Rev Oncol Hematol. 2010;75(3):243–8.

    Article  PubMed  Google Scholar 

  48. Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol. 2012;13(10):e437–44.

    Article  PubMed  Google Scholar 

  49. McCorkle R, Strumpf NE, Nuamah IF, Adler DC, Cooley ME, Jepson C, et al. A specialized home care intervention improves survival among older post-surgical cancer patients. J Am Geriatr Soc. 2000;48(12):1707–13.

    CAS  PubMed  Google Scholar 

  50. Goodwin JS, Satish S, Anderson ET, Nattinger AB, Freeman JL. Effect of nurse case management on the treatment of older women with breast cancer. J Am Geriatr Soc. 2003;51(9):1252–9.

    Article  PubMed  Google Scholar 

  51. Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010;28(2):340–7.

    Article  CAS  PubMed  Google Scholar 

  52. Rao AV, Hsieh F, Feussner JR, Cohen HJ. Geriatric evaluation and management units in the care of the frail elderly cancer patient. J Gerontol A Biol Sci Med Sci. 2005;60(6):798–803.

    Article  PubMed  Google Scholar 

  53. Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol. 2009;27(27):4605–12.

    Article  PubMed  Google Scholar 

  54. Morey MC, Snyder DC, Sloane R, Cohen HJ, Peterson B, Hartman TJ, et al. Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial. JAMA. 2009;301(18):1883–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  55. Demark-Wahnefried W, Clipp EC, Lipkus IM, Lobach D, Snyder DC, Sloane R, et al. Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J Clin Oncol. 2007;25(19):2709–18.

    Article  PubMed  Google Scholar 

  56. Soubeyran P, Khaled H, MacKenzie M, Debois M, Fortpied C, de Bock R, et al. Diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma in the frail elderly: a phase II EORTC trial with a progressive and cautious treatment emphasizing geriatric assessment. J Geriatr Oncol. 2011;2(1):36–44.

    Article  Google Scholar 

  57. Tirelli U, Errante D, Van Glabbeke M, Teodorovic I, Kluin-Nelemans JC, Thomas J, et al. CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol. 1998;16(1):27–34.

    CAS  PubMed  Google Scholar 

  58. Thieblemont C, Grossoeuvre A, Houot R, Broussais-Guillaumont F, Salles G, Traulle C, et al. Non-Hodgkin’s lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome. Ann Oncol. 2008;19(4):774–9.

    Article  CAS  PubMed  Google Scholar 

  59. Monfardini S, Aversa SM, Zoli V, Salvagno L, Bianco A, Bordonaro R, et al. Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin’s lymphomas. Ann Oncol. 2005;16(8):1352–8.

    Article  CAS  PubMed  Google Scholar 

  60. Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile JF, Castaigne S, et al. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2011;12(5):460–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Institut Bergonié, 229 cours de l’Argonne, 33076, Bordeaux Cedex, France

    Pierre Soubeyran MD & Camille Chakiba MD

  2. Site de Recherche Intégrée sur le Cancer, BRIO (Bordeaux Recherche Intégrée Oncologie), 229 cours de l’Argonne, 33076, Bordeaux Cedex, France

    Pierre Soubeyran MD & Camille Chakiba MD

  3. Université Bordeaux Segalen, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France

    Pierre Soubeyran MD

  4. Department of Hematology, Hôpital Lyon-Sud, Hospices Civils de Lyon, Lyon, France

    Anne-Sophie Michallet MD

Authors
  1. Pierre Soubeyran MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Camille Chakiba MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anne-Sophie Michallet MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pierre Soubeyran MD .

Editor information

Editors and Affiliations

  1. Department of Palliative Care, University Hospital Jena, Jena, Thüringen, Germany

    Ulrich Wedding

  2. St Helens Teaching Hospital, University of Liverpool, St Helens, United Kingdom

    Riccardo A. Audisio

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Soubeyran, P., Chakiba, C., Michallet, AS. (2015). General Considerations on Treatment in Older Patients with Hematological Malignancies. In: Wedding, U., Audisio, R. (eds) Management of Hematological Cancer in Older People. Springer, London. https://doi.org/10.1007/978-1-4471-2837-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2837-3_15

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2836-6

  • Online ISBN: 978-1-4471-2837-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation